Notably, supplementation with proline or leucine in the absence of HF had no effect on levels of IGFBP‐1 or phosphorylated IGFBP‐1, and there were no changes in the number of viable cells between different treatment conditions (Figure S1). This evidence concerns the gene IGFBP1 and hydrops fetalis.